Cervical Cancer Prevention: What Ghanaian Women Need to Know About Screening and Protection

Cervical cancer remains a significant health threat for women globally, with approximately 11,500 diagnoses annually in the United States alone. In Ghana, where healthcare access varies across regions, understanding prevention strategies is equally crucial. The challenge with cervical cancer is that precancerous cells often develop silently, without noticeable symptoms, meaning many cases are detected only at advanced stages when treatment becomes more difficult and costly.

The good news is that cervical cancer is largely preventable through accessible, evidence-based approaches. Medical professionals recommend three primary strategies to protect cervical health and catch abnormalities early.

Regular Screening: The First Line of Defence

Cervical screening programmes have proven highly effective at detecting precancerous changes before they progress to cancer. Two main screening methods are available: the Pap test (cervical smear) and the HPV test.

The Pap test involves collecting cells from the cervix, which are then examined under a microscope for abnormalities. The HPV test, by contrast, detects the human papillomavirus—a common sexually transmitted infection linked to cervical cancer development. Many women may carry HPV without knowing it, making testing an important diagnostic tool.

Screening frequency depends on age and individual risk factors. Women aged 21-29 should undergo a Pap test every three years, whilst women aged 30-65 benefit from combined Pap and HPV testing every five years. Women over 65 should consult their healthcare provider about whether continued screening remains necessary.

For Ghanaian women, particularly those in areas with limited healthcare infrastructure, discussing screening options with a local health centre or private clinic is an important first step. Some organisations have introduced mobile screening services to reach underserved communities.

Vaccination and Safe Practices

The HPV vaccine offers powerful protection against the virus strains most commonly linked to cervical cancer. Healthcare professionals typically recommend vaccination for people aged 9-12, ideally before sexual activity begins, though vaccination can benefit older individuals as well.

Beyond vaccination, practising safe sex significantly reduces HPV transmission risk. Consistent condom use during vaginal, anal, and oral sex creates a physical barrier that minimises the exchange of bodily fluids. Open communication with sexual partners about sexual health, vaccination status, and STI testing also helps both individuals stay protected.

Why It Matters for Ghana

Ghana's healthcare system faces resource constraints, making prevention particularly valuable compared to treating advanced cancer. Early detection through screening is considerably more cost-effective and has better health outcomes than managing late-stage disease. Additionally, cervical cancer disproportionately affects women in lower-income settings where screening access is limited.

The World Health Organisation has emphasised that cervical cancer elimination is achievable through high vaccination coverage, accessible screening, and timely treatment. For Ghana, strengthening awareness campaigns about these prevention strategies—particularly in rural areas—could significantly reduce cervical cancer burden.

Women should prioritise these three steps: regular screening appropriate to their age, HPV vaccination where available, and safe sexual practices. Many Ghanaian health facilities now offer these services, and several NGOs provide free or subsidised screening in underserved communities. Taking proactive steps today prevents far more serious health and financial consequences later.